Infectious Disease & COVID-19
Infectious Disease Startup & Validations Utilizing RT-PCR
Offering our Turnkey Infectious Disease Program
Whether you are a clinic interested in bringing Infectious Disease testing in-house or an independent lab looking to add it as a new line of testing, we can assist you with getting your lab quickly validated to offer these high-margin tests that can immediately improve patient care outcomes:
- COVID-19
- Wound
- Gastro
- UTI
- STI
- Respiratory (RPP)
- Nail/Fungal
- Women’s Health
- AntiBiotic Resistance (ABR)
The infectious disease diagnostics market is expected to grow at a CAGR of 6.9% from 2020 to reach $42.85 billion by 2027. The growth of this market is mainly attributed to the increasing prevalence of infectious diseases, growing awareness for early disease diagnoses, increasing funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. Moreover, the outbreak of the COVID19 pandemic will result in higher demand for infectious disease diagnostic products.
Our Program Services
Method Validation in as Little as 10 Days
Fully-Interfaced, Cloud-Based Laboratory Information System
Instrument Procurement and Installation
Remote Data Analysis and Data Review
Access to Lighthouse’s Supply Management Software
Expert Guidance on Panel Selection
Initial CLIA Paperwork and State Lab Applications
Lab Staffing (Unrivaled in Quality & Speed)
Physician-Crafted, Customizable Lab Reports
Ongoing Quality Assurance & Quality Management Programs
Lighthouse Lab Services performs coronavirus validation
Is Your Lab Prepared for Life After COVID?
Many laboratories that have been performing COVID testing by PCR are now wondering how their businesses will be impacted as COVID testing volume winds down. Fortunately, Lighthouse Lab Services is here to assist labs with this transition. We offer solutions to help labs pivot to infectious disease (ID) testing to allow them to continue optimizing investments in PCR platforms.
Reimbursement for ID panels is generally higher than rates for COVID testing.
